Smoking Cessation
📧 Sign up to get email alerts when something new happens for Smoking Cessation.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-11-30FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' generic Bupropion hydrochloride under an original application.
-
CLINICAL_TRIALS trial_result · 2020-10-09Clinical Trial Update: Hollings Cancer Center Varenicline Sampling Study [EARLY_Phase 1]
Early Phase 1 trial update on a varenicline sampling study conducted by Hollings Cancer Center; completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-09-22Clinical Trial Update: Motivation Project: Testing Intervention Components for the Smoker Who is Unwilling to Quit [Phase 4]
Phase 4 trial update evaluating intervention components for smokers unwilling to quit; completed study.
-
CLINICAL_TRIALS trial_result · 2020-09-17Clinical Trial Update: A Single Dose-escalation Study of Cytisine in Adult Smokers [Phase 1]
Phase 1 single-dose escalation trial of cytisine in adult smokers completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-25Clinical Trial Update: Heart Rate Variability Biofeedback for Smoking Cessation [Phase 2]
A Phase 2 clinical trial examining heart rate variability biofeedback as a strategy to aid smoking cessation has completed with results post…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-18Clinical Trial Update: Smoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-Cigarettes [NA]
A completed clinical trial on smoking cessation self-help for individuals who use both tobacco cigarettes and e-cigarettes.
-
CLINICAL_TRIALS trial_result · 2020-08-05Clinical Trial Update: Smoking Cessation & Opioid Dependence Treatment Integration [Phase 2, Phase 3]
Phase 2/3 clinical trial update on integrating smoking cessation treatment with opioid dependence therapy; completed with results posted in …
-
FDA approval · 2020-06-30FDA Approved: BUPROPION HYDROCHLORIDE (XL) — Supplemental Application (Exelan Pharmaceuticals Inc.)
FDA approved a supplemental application for bupropion hydrochloride extended-release (XL) from Exelan Pharmaceuticals Inc., enabling continu…
-
CLINICAL_TRIALS trial_result · 2020-05-21Clinical Trial Update: Harnessing the Power of Technology: MOMBA for Postpartum Smoking [Phase 1]
Phase 1 clinical trial investigating MOMBA technology for postpartum smoking cessation; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-05-18Clinical Trial Update: Trial of Cytisine in Adult Smokers [Phase 2]
Phase 2 clinical trial assessing cytisine for smoking cessation completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: Trial to Evaluate the Efficacy of Simvastatin for Smoking Cessation [Phase 2]
Phase 2 trial evaluating simvastatin for smoking cessation has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Effect of Smoking Reduction on Endothelial Glucocalyx and Vascular Function [Phase 4]
Phase 4 clinical trial evaluating how smoking reduction affects endothelial glycocalyx and vascular function.
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: Hospital-based Patient Navigation and Smoking Cessation [NA]
A completed clinical trial evaluating hospital-based patient navigation combined with smoking cessation interventions.
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: Determinants of Smoking Cessation Among Latinos [NA]
A completed clinical trial Investigates determinants of smoking cessation among Latino participants; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-16Clinical Trial Update: Genetically Informed Smoking Cessation Trial [Phase 4]
Phase 4 trial update on a genetically informed smoking cessation study, with completed status and results posted.
-
FDA approval · 2020-03-05FDA Approved: BUPROPION — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Bupropion by Zydus Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2020-02-19Clinical Trial Update: Providing Free Nicotine Patches to Quitline Smokers [Phase 3]
Phase 3 trial updating outcomes of providing free nicotine patches to individuals seeking help with smoking cessation; results have been pos…
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: The Long-Term Quitting (Smoking Cessation) Study [Phase 4]
A Phase 4 clinical trial on smoking cessation has been completed.
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: Telephone Counseling and the Distribution of Nicotine Patches to Smokers [Phase 3]
Phase 3 trial update on telephone counseling and distribution of nicotine patches for smoking cessation; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: A Text Messaging Program for Smokers in Primary Care [Phase 4]
Phase 4 clinical trial update on a text messaging program for smoking cessation in primary care; results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-29Clinical Trial Update: Smoking Cessation Treatment for Methadone Maintenance Patients [Phase 4]
A Phase 4 trial evaluating smoking cessation treatment in patients on methadone maintenance has completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-23Clinical Trial Update: Smoking Cessation Intervention [Phase 4]
Phase 4 clinical trial on a smoking cessation intervention has been terminated.
-
FDA approval · 2019-12-27FDA Approved: NICOTINE MINI — Supplemental Application (Walgreen Company)
FDA approved a supplemental application for NICOTINE MINI (nicotine polacrilex), submitted by Walgreens, under ANDA203690.
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: Evaluation of National Cancer Institute Young Adult Stop-Smoking Program [Phase 2]
Phase 2 clinical trial update on the National Cancer Institute's Young Adult Stop-Smoking Program completed.
-
FDA approval · 2019-11-15FDA Approved: NICORETTE 4MG FRUIT CHILL GUM, LIL DRUG STORE — Supplemental Application (Lil' Drug Store Products, Inc.)
FDA approved a supplemental application to market NICORETTE 4MG Fruit Chill Gum by Lil' Drug Store Products, Inc., with nicotine polacrilex …